Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
Is a |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
Is a |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 10mg/5mL s/f liquid |
Is a |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine measurement |
Has measured component |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine measurement |
Component |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paroxetine hydrochloride 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine hydrochloride 40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine hydrochloride 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine hydrochloride 30mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 25mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 12.5mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 37.5mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 25mg gastro-resistant and prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paroxetine hydrochloride hemihydrate (substance) |
Is modification of (attribute) |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paroxetine hydrochloride anhydrous (substance) |
Is modification of (attribute) |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paroxetine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |